APO Research

APO RESEARCH · REPORT

Pharmaceutical Propellants

Selected research

Industry Growth & Trends

Global Pharmaceutical Propellants Industry Growth and Trends Forecast to 2032

Market perspective

The global Pharmaceutical Propellants market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pharmaceutical Propellants is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Propellants is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Propellants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharmaceutical Propellants include Yara International, The Linde Group, SRF, Solvay, DAIKIN Chemical, AlzChem and Akzo Nobel, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pharmaceutical Propellants market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pharmaceutical Propellants market size, estimates, and forecasts are presented in terms of sales volume (k tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pharmaceutical Propellants market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pharmaceutical Propellants.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pharmaceutical Propellants market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pharmaceutical Propellants Market by Company

Yara International

The Linde Group

SRF

Solvay

DAIKIN Chemical

AlzChem

Akzo Nobel

Pharmaceutical Propellants Segment by Type

Liquefied Gases

Compressed Gases

Pharmaceutical Propellants Segment by Application

Asthma Sprays

Foam Sprays

Oral and Topical Sprays

Nasal Sprays

Pharmaceutical Propellants Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Propellants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Propellants and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Propellants.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pharmaceutical Propellants manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pharmaceutical Propellants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Liquefied Gases Table 2. Major Company of Compressed Gases Table 3. Global Pharmaceutical Propellants Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Pharmaceutical Propellants Sales by Type (2021-2026) & (k tons) Table 5. Global Pharmaceutical Propellants Sales Market Share in Volume by Type (2021-2026) Table 6. Global Pharmaceutical Propellants Sales by Type (2021-2026) & (US$ Million) Table 7. Global Pharmaceutical Propellants Sales Market Share in Value by Type (2021-2026) Table 8. Global Pharmaceutical Propellants Price by Type (2021-2026) & (US$/ton) Table 9. Global Pharmaceutical Propellants Sales by Type (2027-2032) & (k tons) Table 10. Global Pharmaceutical Propellants Sales Market Share in Volume by Type (2027-2032) Table 11. Global Pharmaceutical Propellants Sales by Type (2027-2032) & (US$ Million) Table 12. Global Pharmaceutical Propellants Sales Market Share in Value by Type (2027-2032) Table 13. Global Pharmaceutical Propellants Price by Type (2027-2032) & (US$/ton) Table 14. North America Pharmaceutical Propellants Sales by Type (2021-2026) & (k tons) Table 15. North America Pharmaceutical Propellants Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Pharmaceutical Propellants Sales by Type (2021-2026) & (k tons) Table 17. Europe Pharmaceutical Propellants Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Pharmaceutical Propellants Sales by Type (2021-2026) & (k tons) Table 19. Asia-Pacific Pharmaceutical Propellants Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Pharmaceutical Propellants Sales by Type (2021-2026) & (k tons) Table 21. Latin America Pharmaceutical Propellants Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Pharmaceutical Propellants Sales by Type (2021-2026) & (k tons) Table 23. Middle East and Africa Pharmaceutical Propellants Sales by Type (2021-2026) & (US$ Million) Table 24. Pharmaceutical Propellants Industry Trends Table 25. Pharmaceutical Propellants Industry Drivers Table 26. Pharmaceutical Propellants Industry Opportunities and Challenges Table 27. Pharmaceutical Propellants Industry Restraints Table 28. Global Pharmaceutical Propellants Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Pharmaceutical Propellants Revenue Market Share by Company (2021-2026) Table 30. Global Pharmaceutical Propellants Sales by Company (2021-2026) & (k tons) Table 31. Global Pharmaceutical Propellants Sales Share by Company (2021-2026) Table 32. Global Pharmaceutical Propellants Market Price by Company (2021-2026) & (US$/ton) Table 33. Global Pharmaceutical Propellants Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Pharmaceutical Propellants Major Company Production Sites and Headquarters Table 35. Global Pharmaceutical Propellants Company, Product Type & Application Table 36. Global Pharmaceutical Propellants Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Pharmaceutical Propellants by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Pharmaceutical Propellants Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Pharmaceutical Propellants Sales by Region (2021-2026) & (k tons) Table 41. Global Pharmaceutical Propellants Sales Market Share in Volume by Region (2021-2026) Table 42. Global Pharmaceutical Propellants Sales by Region (2021-2026) & (US$ Million) Table 43. Global Pharmaceutical Propellants Sales Market Share in Value by Region (2021-2026) Table 44. Global Pharmaceutical Propellants Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 45. Global Pharmaceutical Propellants Sales by Region (2027-2032) & (k tons) Table 46. Global Pharmaceutical Propellants Sales Market Share in Volume by Region (2027-2032) Table 47. Global Pharmaceutical Propellants Sales by Region (2027-2032) & (US$ Million) Table 48. Global Pharmaceutical Propellants Sales Market Share in Value by Region (2027-2032) Table 49. Global Pharmaceutical Propellants Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2027-2032) Table 50. Global Pharmaceutical Propellants Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Pharmaceutical Propellants Sales by Application (2021-2026) & (k tons) Table 52. Global Pharmaceutical Propellants Sales Market Share in Volume by Application (2021-2026) Table 53. Global Pharmaceutical Propellants Sales by Application (2021-2026) & (US$ Million) Table 54. Global Pharmaceutical Propellants Sales Market Share in Value by Application (2021-2026) Table 55. Global Pharmaceutical Propellants Price by Application (2021-2026) & (US$/ton) Table 56. Global Pharmaceutical Propellants Sales by Application (2027-2032) & (k tons) Table 57. Global Pharmaceutical Propellants Sales Market Share in Volume by Application (2027-2032) Table 58. Global Pharmaceutical Propellants Sales by Application (2027-2032) & (US$ Million) Table 59. Global Pharmaceutical Propellants Sales Market Share in Value by Application (2027-2032) Table 60. Global Pharmaceutical Propellants Price by Application (2027-2032) & (US$/ton) Table 61. North America Pharmaceutical Propellants Sales by Application (2021-2026) & (k tons) Table 62. North America Pharmaceutical Propellants Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Pharmaceutical Propellants Sales by Application (2021-2026) & (k tons) Table 64. Europe Pharmaceutical Propellants Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Pharmaceutical Propellants Sales by Application (2021-2026) & (k tons) Table 66. Asia-Pacific Pharmaceutical Propellants Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Pharmaceutical Propellants Sales by Application (2021-2026) & (k tons) Table 68. Latin America Pharmaceutical Propellants Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Pharmaceutical Propellants Sales by Application (2021-2026) & (k tons) Table 70. Middle East and Africa Pharmaceutical Propellants Sales by Application (2021-2026) & (US$ Million) Table 71. Yara International Company Information Table 72. Yara International Business Overview Table 73. Yara International Pharmaceutical Propellants Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 74. Yara International Pharmaceutical Propellants Product Portfolio Table 75. Yara International Recent Development Table 76. The Linde Group Company Information Table 77. The Linde Group Business Overview Table 78. The Linde Group Pharmaceutical Propellants Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 79. The Linde Group Pharmaceutical Propellants Product Portfolio Table 80. The Linde Group Recent Development Table 81. SRF Company Information Table 82. SRF Business Overview Table 83. SRF Pharmaceutical Propellants Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 84. SRF Pharmaceutical Propellants Product Portfolio Table 85. SRF Recent Development Table 86. Solvay Company Information Table 87. Solvay Business Overview Table 88. Solvay Pharmaceutical Propellants Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 89. Solvay Pharmaceutical Propellants Product Portfolio Table 90. Solvay Recent Development Table 91. DAIKIN Chemical Company Information Table 92. DAIKIN Chemical Business Overview Table 93. DAIKIN Chemical Pharmaceutical Propellants Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 94. DAIKIN Chemical Pharmaceutical Propellants Product Portfolio Table 95. DAIKIN Chemical Recent Development Table 96. AlzChem Company Information Table 97. AlzChem Business Overview Table 98. AlzChem Pharmaceutical Propellants Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 99. AlzChem Pharmaceutical Propellants Product Portfolio Table 100. AlzChem Recent Development Table 101. Akzo Nobel Company Information Table 102. Akzo Nobel Business Overview Table 103. Akzo Nobel Pharmaceutical Propellants Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 104. Akzo Nobel Pharmaceutical Propellants Product Portfolio Table 105. Akzo Nobel Recent Development Table 106. North America Pharmaceutical Propellants Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 107. North America Pharmaceutical Propellants Sales by Country (2021-2026) & (k tons) Table 108. North America Pharmaceutical Propellants Sales Market Share by Country (2021-2026) Table 109. North America Pharmaceutical Propellants Sales Forecast by Country (2027-2032) & (k tons) Table 110. North America Pharmaceutical Propellants Sales Market Share Forecast by Country (2027-2032) Table 111. North America Pharmaceutical Propellants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Pharmaceutical Propellants Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Pharmaceutical Propellants Market Share by Country (2021-2026) Table 114. North America Pharmaceutical Propellants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Pharmaceutical Propellants Market Share Forecast by Country (2027-2032) Table 116. Europe Pharmaceutical Propellants Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 117. Europe Pharmaceutical Propellants Sales by Country (2021-2026) & (k tons) Table 118. Europe Pharmaceutical Propellants Sales Market Share by Country (2021-2026) Table 119. Europe Pharmaceutical Propellants Sales Forecast by Country (2027-2032) & (k tons) Table 120. Europe Pharmaceutical Propellants Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Pharmaceutical Propellants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Pharmaceutical Propellants Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Pharmaceutical Propellants Market Share by Country (2021-2026) Table 124. Europe Pharmaceutical Propellants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Pharmaceutical Propellants Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Pharmaceutical Propellants Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Pharmaceutical Propellants Sales by Country (2021-2026) & (k tons) Table 128. Asia-Pacific Pharmaceutical Propellants Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Pharmaceutical Propellants Sales Forecast by Country (2027-2032) & (k tons) Table 130. Asia-Pacific Pharmaceutical Propellants Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Pharmaceutical Propellants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Pharmaceutical Propellants Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Pharmaceutical Propellants Market Share by Country (2021-2026) Table 134. Asia-Pacific Pharmaceutical Propellants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Pharmaceutical Propellants Market Share Forecast by Country (2027-2032) Table 136. Latin America Pharmaceutical Propellants Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 137. Latin America Pharmaceutical Propellants Sales by Country (2021-2026) & (k tons) Table 138. Latin America Pharmaceutical Propellants Sales Market Share by Country (2021-2026) Table 139. Latin America Pharmaceutical Propellants Sales Forecast by Country (2027-2032) & (k tons) Table 140. Latin America Pharmaceutical Propellants Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Pharmaceutical Propellants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Pharmaceutical Propellants Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Pharmaceutical Propellants Market Share by Country (2021-2026) Table 144. Latin America Pharmaceutical Propellants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Pharmaceutical Propellants Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Pharmaceutical Propellants Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Pharmaceutical Propellants Sales by Country (2021-2026) & (k tons) Table 148. Middle East and Africa Pharmaceutical Propellants Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Pharmaceutical Propellants Sales Forecast by Country (2027-2032) & (k tons) Table 150. Middle East and Africa Pharmaceutical Propellants Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Pharmaceutical Propellants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Pharmaceutical Propellants Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Pharmaceutical Propellants Market Share by Country (2021-2026) Table 154. Middle East and Africa Pharmaceutical Propellants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Pharmaceutical Propellants Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Pharmaceutical Propellants Distributors List Table 159. Pharmaceutical Propellants Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Pharmaceutical Propellants Image Figure 2. Global Pharmaceutical Propellants Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Propellants Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Propellants Sales (2021-2032) & (k tons) Figure 5. Liquefied Gases Image Figure 6. Global Liquefied Gases Sales YoY Growth (2021-2032) & (k tons) Figure 7. Compressed Gases Image Figure 8. Global Compressed Gases Sales YoY Growth (2021-2032) & (k tons) Figure 9. Global Pharmaceutical Propellants Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Pharmaceutical Propellants Market Share by Type 2025 VS 2032 Figure 11. North America Pharmaceutical Propellants Sales Market Share in Volume by Type in 2025 Figure 12. North America Pharmaceutical Propellants Sales Market Share in Value by Type in 2025 Figure 13. Europe Pharmaceutical Propellants Sales Market Share in Volume by Type in 2025 Figure 14. Europe Pharmaceutical Propellants Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Pharmaceutical Propellants Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Pharmaceutical Propellants Sales Market Share in Value by Type in 2025 Figure 17. Latin America Pharmaceutical Propellants Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Pharmaceutical Propellants Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Pharmaceutical Propellants Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Pharmaceutical Propellants Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Pharmaceutical Propellants Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Asthma Sprays Image Figure 24. Global Asthma Sprays Sales YoY Growth (2021-2032) & (k tons) Figure 25. Foam Sprays Image Figure 26. Global Foam Sprays Sales YoY Growth (2021-2032) & (k tons) Figure 27. Oral and Topical Sprays Image Figure 28. Global Oral and Topical Sprays Sales YoY Growth (2021-2032) & (k tons) Figure 29. Nasal Sprays Image Figure 30. Global Nasal Sprays Sales YoY Growth (2021-2032) & (k tons) Figure 31. Global Pharmaceutical Propellants Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Pharmaceutical Propellants Market Share by Application 2025 VS 2032 Figure 33. North America Pharmaceutical Propellants Sales Market Share in Volume by Application in 2025 Figure 34. North America Pharmaceutical Propellants Sales Market Share in Value by Application in 2025 Figure 35. Europe Pharmaceutical Propellants Sales Market Share in Volume by Application in 2025 Figure 36. Europe Pharmaceutical Propellants Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Pharmaceutical Propellants Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Pharmaceutical Propellants Sales Market Share in Value by Application in 2025 Figure 39. Latin America Pharmaceutical Propellants Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Pharmaceutical Propellants Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Pharmaceutical Propellants Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Pharmaceutical Propellants Sales Market Share in Value by Application in 2025 Figure 43. North America Pharmaceutical Propellants Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 44. North America Pharmaceutical Propellants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Pharmaceutical Propellants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Pharmaceutical Propellants Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pharmaceutical Propellants Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 48. Europe Pharmaceutical Propellants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Pharmaceutical Propellants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Pharmaceutical Propellants Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Pharmaceutical Propellants Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 52. Asia-Pacific Pharmaceutical Propellants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Pharmaceutical Propellants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Pharmaceutical Propellants Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pharmaceutical Propellants Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 56. Latin America Pharmaceutical Propellants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Pharmaceutical Propellants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Pharmaceutical Propellants Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Pharmaceutical Propellants Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 60. Middle East and Africa Pharmaceutical Propellants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Pharmaceutical Propellants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Pharmaceutical Propellants Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Pharmaceutical Propellants Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Pharmaceutical Propellants Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Liquefied Gases
  • Compressed Gases
Applications
  • Asthma Sprays
  • Foam Sprays
  • Oral and Topical Sprays
  • Nasal Sprays
Companies covered
  • Yara International
  • The Linde Group
  • SRF
  • Solvay
  • DAIKIN Chemical
  • AlzChem
  • Akzo Nobel

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pharmaceutical Propellants Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pharmaceutical Propellants Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pharmaceutical Propellants Market by Type
  6. 1.3.1 Liquefied Gases
  7. 1.3.2 Compressed Gases
  8. 1.4 Global Pharmaceutical Propellants Market Size by Type
  9. 1.4.1 Global Pharmaceutical Propellants Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Pharmaceutical Propellants Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Pharmaceutical Propellants Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Pharmaceutical Propellants Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Pharmaceutical Propellants Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Pharmaceutical Propellants Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Pharmaceutical Propellants Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Pharmaceutical Propellants Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pharmaceutical Propellants Industry Trends
  2. 2.2 Pharmaceutical Propellants Industry Drivers
  3. 2.3 Pharmaceutical Propellants Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Propellants Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pharmaceutical Propellants Revenue (2021-2026)
  2. 3.2 Global Top Players by Pharmaceutical Propellants Sales (2021-2026)
  3. 3.3 Global Top Players by Pharmaceutical Propellants Price (2021-2026)
  4. 3.4 Global Pharmaceutical Propellants Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pharmaceutical Propellants Major Company Production Sites & Headquarters
  6. 3.6 Global Pharmaceutical Propellants Company, Product Type & Application
  7. 3.7 Global Pharmaceutical Propellants Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pharmaceutical Propellants Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pharmaceutical Propellants Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pharmaceutical Propellants Tier 1, Tier 2, and Tier 3
4 Pharmaceutical Propellants Regional Status and Outlook
  1. 4.1 Global Pharmaceutical Propellants Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pharmaceutical Propellants Historic Market Size by Region
  3. 4.2.1 Global Pharmaceutical Propellants Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pharmaceutical Propellants Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pharmaceutical Propellants Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pharmaceutical Propellants Forecasted Market Size by Region
  7. 4.3.1 Global Pharmaceutical Propellants Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pharmaceutical Propellants Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pharmaceutical Propellants Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pharmaceutical Propellants by Application
  1. 5.1 Pharmaceutical Propellants Market by Application
  2. 5.1.1 Asthma Sprays
  3. 5.1.2 Foam Sprays
  4. 5.1.3 Oral and Topical Sprays
  5. 5.1.4 Nasal Sprays
  6. 5.2 Global Pharmaceutical Propellants Market Size by Application
  7. 5.2.1 Global Pharmaceutical Propellants Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Pharmaceutical Propellants Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Pharmaceutical Propellants Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Pharmaceutical Propellants Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Pharmaceutical Propellants Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Pharmaceutical Propellants Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Pharmaceutical Propellants Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Pharmaceutical Propellants Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Yara International
  2. 6.1.1 Yara International Company Information
  3. 6.1.2 Yara International Business Overview
  4. 6.1.3 Yara International Pharmaceutical Propellants Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Yara International Pharmaceutical Propellants Product Portfolio
  6. 6.1.5 Yara International Recent Developments
  7. 6.2 The Linde Group
  8. 6.2.1 The Linde Group Company Information
  9. 6.2.2 The Linde Group Business Overview
  10. 6.2.3 The Linde Group Pharmaceutical Propellants Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 The Linde Group Pharmaceutical Propellants Product Portfolio
  12. 6.2.5 The Linde Group Recent Developments
  13. 6.3 SRF
  14. 6.3.1 SRF Company Information
  15. 6.3.2 SRF Business Overview
  16. 6.3.3 SRF Pharmaceutical Propellants Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 SRF Pharmaceutical Propellants Product Portfolio
  18. 6.3.5 SRF Recent Developments
  19. 6.4 Solvay
  20. 6.4.1 Solvay Company Information
  21. 6.4.2 Solvay Business Overview
  22. 6.4.3 Solvay Pharmaceutical Propellants Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Solvay Pharmaceutical Propellants Product Portfolio
  24. 6.4.5 Solvay Recent Developments
  25. 6.5 DAIKIN Chemical
  26. 6.5.1 DAIKIN Chemical Company Information
  27. 6.5.2 DAIKIN Chemical Business Overview
  28. 6.5.3 DAIKIN Chemical Pharmaceutical Propellants Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 DAIKIN Chemical Pharmaceutical Propellants Product Portfolio
  30. 6.5.5 DAIKIN Chemical Recent Developments
  31. 6.6 AlzChem
  32. 6.6.1 AlzChem Company Information
  33. 6.6.2 AlzChem Business Overview
  34. 6.6.3 AlzChem Pharmaceutical Propellants Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AlzChem Pharmaceutical Propellants Product Portfolio
  36. 6.6.5 AlzChem Recent Developments
  37. 6.7 Akzo Nobel
  38. 6.7.1 Akzo Nobel Company Information
  39. 6.7.2 Akzo Nobel Business Overview
  40. 6.7.3 Akzo Nobel Pharmaceutical Propellants Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Akzo Nobel Pharmaceutical Propellants Product Portfolio
  42. 6.7.5 Akzo Nobel Recent Developments
7 North America by Country
  1. 7.1 North America Pharmaceutical Propellants Sales by Country
  2. 7.1.1 North America Pharmaceutical Propellants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pharmaceutical Propellants Sales by Country (2021-2026)
  4. 7.1.3 North America Pharmaceutical Propellants Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pharmaceutical Propellants Market Size by Country
  6. 7.2.1 North America Pharmaceutical Propellants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pharmaceutical Propellants Market Size by Country (2021-2026)
  8. 7.2.3 North America Pharmaceutical Propellants Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pharmaceutical Propellants Sales by Country
  2. 8.1.1 Europe Pharmaceutical Propellants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pharmaceutical Propellants Sales by Country (2021-2026)
  4. 8.1.3 Europe Pharmaceutical Propellants Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pharmaceutical Propellants Market Size by Country
  6. 8.2.1 Europe Pharmaceutical Propellants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pharmaceutical Propellants Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pharmaceutical Propellants Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pharmaceutical Propellants Sales by Country
  2. 9.1.1 Asia-Pacific Pharmaceutical Propellants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pharmaceutical Propellants Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pharmaceutical Propellants Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pharmaceutical Propellants Market Size by Country
  6. 9.2.1 Asia-Pacific Pharmaceutical Propellants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pharmaceutical Propellants Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pharmaceutical Propellants Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pharmaceutical Propellants Sales by Country
  2. 10.1.1 South America Pharmaceutical Propellants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pharmaceutical Propellants Sales by Country (2021-2026)
  4. 10.1.3 South America Pharmaceutical Propellants Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pharmaceutical Propellants Market Size by Country
  6. 10.2.1 South America Pharmaceutical Propellants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pharmaceutical Propellants Market Size by Country (2021-2026)
  8. 10.2.3 South America Pharmaceutical Propellants Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pharmaceutical Propellants Sales by Country
  2. 11.1.1 Middle East and Africa Pharmaceutical Propellants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pharmaceutical Propellants Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pharmaceutical Propellants Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pharmaceutical Propellants Market Size by Country
  6. 11.2.1 Middle East and Africa Pharmaceutical Propellants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pharmaceutical Propellants Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pharmaceutical Propellants Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pharmaceutical Propellants Value Chain Analysis
  2. 12.1.1 Pharmaceutical Propellants Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pharmaceutical Propellants Production Mode & Process
  7. 12.2 Pharmaceutical Propellants Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pharmaceutical Propellants Distributors
  10. 12.2.3 Pharmaceutical Propellants Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research